InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Ostrowski Erik. Officer active across 2 companies, notably AVROBIO, Inc.. Aggregated, 7 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €170k. Activity tracked since 1 February 2024. The latest transaction was disclosed on 2 February 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Ostrowski Erik is a declarant linked to Akebia Therapeutics, Inc., where he is SVP, CFO, CBO & Treasurer, and to AVROBIO, Inc., where he is Interim CEO, President and CFO. He has filed 7 filings in total, and across the sampled recent filings between 2024-02-05 and 2026-07-01, the modal transaction nature is Sale, with total sell volume of EUR 169634 and no buys.